Literature DB >> 26770356

Association between Cytotoxic T-lymphocyte antigen 4 (CTLA-4) +49 G>A (rs231775) polymorphism and esophageal cancer: from a case-control study to a meta-analysis.

Chao Liu1, Yafeng Wang2, Heping Jiang3, Weifeng Tang4, Shuchen Chen5, Mingqiang Kang5, Changqing Dong1, Haiyong Gu1.   

Abstract

The aim of this study was to evaluate the association between CTLA-4 +49 G>A polymorphism and esophageal cancer (EC) susceptibility in a hospital based case-control study and a subsequent meta-analysis. We implemented genotyping analyses for CTLA-4 +49 G>A polymorphism with 629 esophageal squamous cell carcinoma cases and 686 controls in a Chinese Han population. Polymerase chain reaction ligase detection reaction (PCR-LDR) method was used to identify genotypes of CTLA-4 +49 G>A polymorphism. We first assessed the association between CTLA-4 +49 G>A polymorphism and EC risk in a hospital based case-control study, and then performed a comprehensive meta-analysis to derive a more precise estimation. Our results demonstrated that CTLA-4 +49 G>A polymorphism was not associated with EC risk. This case-control study and further meta-analysis, failed to identify the association between CTLA-4 +49 G>A polymorphism and EC risk. And additional, further well designed studies with large sample sizes and detailed gene-environment data are required.

Entities:  

Keywords:  CTLA4; esophageal cancer; meta-analysis; polymorphism; susceptibility

Year:  2015        PMID: 26770356      PMCID: PMC4694256     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  22 in total

1.  Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease.

Authors:  Hironori Ueda; Joanna M M Howson; Laura Esposito; Joanne Heward; Hywel Snook; Giselle Chamberlain; Daniel B Rainbow; Kara M D Hunter; Annabel N Smith; Gianfranco Di Genova; Mathias H Herr; Ingrid Dahlman; Felicity Payne; Deborah Smyth; Christopher Lowe; Rebecca C J Twells; Sarah Howlett; Barry Healy; Sarah Nutland; Helen E Rance; Vin Everett; Luc J Smink; Alex C Lam; Heather J Cordell; Neil M Walker; Cristina Bordin; John Hulme; Costantino Motzo; Francesco Cucca; J Fred Hess; Michael L Metzker; Jane Rogers; Simon Gregory; Amit Allahabadia; Ratnasingam Nithiyananthan; Eva Tuomilehto-Wolf; Jaakko Tuomilehto; Polly Bingley; Kathleen M Gillespie; Dag E Undlien; Kjersti S Rønningen; Cristian Guja; Constantin Ionescu-Tîrgovişte; David A Savage; A Peter Maxwell; Dennis J Carson; Chris C Patterson; Jayne A Franklyn; David G Clayton; Laurence B Peterson; Linda S Wicker; John A Todd; Stephen C L Gough
Journal:  Nature       Date:  2003-04-30       Impact factor: 49.962

2.  GSTT1, GSTM1 and GSTP1 genetic polymorphisms and interaction with tobacco, alcohol and occupational exposure in esophageal cancer patients from North India.

Authors:  Meenu Jain; Shaleen Kumar; Neeraj Rastogi; Punita Lal; Uday C Ghoshal; Anu Tiwari; Mohan C Pant; Mirza Q Baiq; Balraj Mittal
Journal:  Cancer Lett       Date:  2005-12-07       Impact factor: 8.679

3.  [Application of Stata software to test heterogeneity in meta-analysis method].

Authors:  Dan Wang; Zhen-yun Mou; Jun-xia Zhai; Hong-xia Zong; Xiao-dong Zhao
Journal:  Zhonghua Liu Xing Bing Xue Za Zhi       Date:  2008-07

4.  Meta-analysis in clinical trials.

Authors:  R DerSimonian; N Laird
Journal:  Control Clin Trials       Date:  1986-09

5.  Modeling gene-environment interactions in oral cavity and esophageal cancers demonstrates a role for the p53 R72P polymorphism in modulating susceptibility.

Authors:  Jayanta Sarkar; Emily Dominguez; Guojun Li; Donna F Kusewitt; David G Johnson
Journal:  Mol Carcinog       Date:  2013-03-08       Impact factor: 4.784

6.  Report of incidence and mortality in China cancer registries, 2009.

Authors:  Wanqing Chen; Rongshou Zheng; Siwei Zhang; Ping Zhao; Guanglin Li; Lingyou Wu; Jie He
Journal:  Chin J Cancer Res       Date:  2013-02       Impact factor: 5.087

7.  Functional genetic variations in cytotoxic T-lymphocyte antigen 4 and susceptibility to multiple types of cancer.

Authors:  Tong Sun; Yifeng Zhou; Ming Yang; Zhibin Hu; Wen Tan; Xiaohong Han; Yuankai Shi; Jiarui Yao; Yongli Guo; Dianke Yu; Tian Tian; Xiaoyi Zhou; Hongbing Shen; Dongxin Lin
Journal:  Cancer Res       Date:  2008-09-01       Impact factor: 12.701

8.  Epigenetic, genetic and environmental interactions in esophageal squamous cell carcinoma from northeast India.

Authors:  Fazlur Rahman Talukdar; Sankar Kumar Ghosh; Ruhina Shirin Laskar; Rosy Mondal
Journal:  PLoS One       Date:  2013-04-15       Impact factor: 3.240

9.  Interaction between alcohol consumption and CYP 2C19 gene polymorphism in relation to oesophageal squamous cell carcinoma.

Authors:  Yun Shi; Guo-jun Luo; Li Zhang; Ji Shi; Dao-quan Zhang; Jian-min Chen; Xiao-bo Chen; Zhuo-dong Li; Qing Zhao
Journal:  PLoS One       Date:  2012-09-11       Impact factor: 3.240

10.  Hsa-miR-34b/c rs4938723 T>C and hsa-miR-423 rs6505162 C>A polymorphisms are associated with the risk of esophageal cancer in a Chinese population.

Authors:  Jun Yin; Xu Wang; Liang Zheng; Yijun Shi; Liming Wang; Aizhong Shao; Weifeng Tang; Guowen Ding; Chao Liu; Ruiping Liu; Suocheng Chen; Haiyong Gu
Journal:  PLoS One       Date:  2013-11-18       Impact factor: 3.240

View more
  3 in total

1.  Comprehensive Analysis of 29,464 Cancer Cases and 35,858 Controls to Investigate the Effect of the Cytotoxic T-Lymphocyte Antigen 4 Gene rs231775 A/G Polymorphism on Cancer Risk.

Authors:  Hongyuan Wan; Hangsheng Zhou; Yanyan Feng; Yongquan Chen; Lijie Zhu; Yuanyuan Mi
Journal:  Front Oncol       Date:  2022-05-04       Impact factor: 5.738

Review 2.  Advances in T-cell checkpoint immunotherapy for head and neck squamous cell carcinoma.

Authors:  Xinmeng Qi; Bo Jia; Xue Zhao; Dan Yu
Journal:  Onco Targets Ther       Date:  2017-12-01       Impact factor: 4.147

Review 3.  Cumulative evidence for association between genetic polymorphisms and esophageal cancer susceptibility: A review with evidence from meta-analysis and genome-wide association studies.

Authors:  Jie Tian; Caiyang Liu; Guanchu Liu; Chunjian Zuo; Huanwen Chen
Journal:  Cancer Med       Date:  2019-02-21       Impact factor: 4.452

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.